Koyfin Home > Directory > Health Care > Amgen Inc > EBITDA

Amgen Inc EBITDA Chart (AMGN)

Amgen Inc annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Amgen Inc EBITDA for the quarter ending June 06, 2020 was $3,253m a 8.27% increase of 269m year over year
  • Amgen Inc EBITDA for the last 12 months ending June 06, 2020 was $12,115m a 1.28% increase of 155m year over year
  • Amgen Inc Annual EBITDA for 2019 was $11,756m a -6.17% decrease of -725m from 2018
  • Amgen Inc Annual EBITDA for 2018 was $12,481m a 1.90% increase of 237m from 2017
  • Amgen Inc Annual EBITDA for 2017 was $12,244m a 2.51% increase of 307m from 2016
Other Income Statement Metrics:
  • Amgen Inc Net Income for the quarter ending December 12, 2018 was $1,928m a -19.87% decrease of -383m year over year
  • Amgen Inc Total Revenue for the quarter ending December 12, 2018 was $6,230m a 10.85% increase of 676m year over year
View Chart On Koyfin

Quarterly AMGN EBITDA Data

06/2020$3,253m
03/2020$3,252m
12/2019$2,626m
09/2019$2,984m
06/2019$3,179m
03/2019$2,967m
12/2018$2,814m
09/2018$3,154m
06/2018$3,316m
03/2018$3,197m

Annual AMGN EBITDA Data

2019$11,756m
2018$12,481m
2017$12,244m
2016$11,937m
2015$10,637m
2014$8,802m
2013$7,391m
2012$7,057m
2011$6,279m
2010$6,609m